000 | 01815 a2200469 4500 | ||
---|---|---|---|
005 | 20250514072041.0 | ||
264 | 0 | _c20040422 | |
008 | 200404s 0 0 eng d | ||
022 | _a0049-3848 | ||
024 | 7 |
_a10.1016/s0049-3848(03)00243-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBrueckmann, Martina | |
245 | 0 | 0 |
_aClinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure. _h[electronic resource] |
260 |
_bThrombosis research _cMar 2003 |
||
300 |
_a259-63 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAnti-Bacterial Agents |
650 | 0 | 4 |
_aAnticoagulants _xpharmacology |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aDisseminated Intravascular Coagulation _xprevention & control |
650 | 0 | 4 | _aDrainage |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 |
_aDrug Therapy, Combination _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKnee Joint _xsurgery |
650 | 0 | 4 |
_aMultiple Organ Failure _xblood |
650 | 0 | 4 |
_aPostoperative Complications _xblood |
650 | 0 | 4 |
_aProtein C _xpharmacology |
650 | 0 | 4 |
_aRecombinant Proteins _xpharmacology |
650 | 0 | 4 |
_aRetropharyngeal Abscess _xdrug therapy |
650 | 0 | 4 |
_aSystemic Inflammatory Response Syndrome _xcomplications |
650 | 0 | 4 |
_aUrinary Catheterization _xadverse effects |
650 | 0 | 4 |
_aUrinary Tract Infections _xcomplications |
700 | 1 | _aWizenmann, Jan | |
700 | 1 | _aHoffmann, Ursula | |
700 | 1 | _aSeeger, Markus | |
700 | 1 | _aBewig, Burkhard | |
773 | 0 |
_tThrombosis research _gvol. 109 _gno. 5-6 _gp. 259-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0049-3848(03)00243-3 _zAvailable from publisher's website |
999 |
_c12601753 _d12601753 |